Back

Obicetrapib–ezetimibe combination therapy: a novel oral strategy for enhanced lipid lowering

Cardiovascular Research

14 August 2026
Organised by: Logo
Read full article
ESC Journals

Contributors

Mitra Chitsazan
Mitra Chitsazan

Author

Mandana Chitsazan
Mandana Chitsazan

Author

Christopher P Cannon
Christopher P Cannon

Author

Brigham and Women's Hospital Boston , United States of America

You may be interested in
thumbnail
Congress Presentation
Obicetrapib and cardiovascular events
1 September 2025
thumbnail
Congress Presentation
Forging the path: strategic combinations to achieve lipid targets
29 August 2025
thumbnail
Congress Session
Novel mechanisms for insights into atherosclerosis
26 August 2023
thumbnail
Congress Presentation
Ezetimibe use and mortality after myocardial infarction: a nationwide cohort study
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources